Atlas Trials

Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

Clinical trial NCT07739368 · COMPLETED

Trial details

NCT number
NCT07739368
Sponsor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Iron Deficiency Anaemia
Start date
2021-09-01
Primary completion
2025-02-20
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.